(TSLX) Sixth Street Specialty - Overview
Sector: Financial Services | Industry: Asset Management | Exchange: NYSE (USA) | Market Cap: 1.657m USD | Total Return: -11.5% in 12m
Avg Trading Vol: 18.3M USD
Peers RS (IBD): 27.7
EPS Trend: -25.0%
Qual. Beats: 0
Rev. Trend: 42.2%
Qual. Beats: 0
Sixth Street Specialty Lending, Inc. (NYSE: TSLX) is a Business Development Company that originates and manages a diversified portfolio of senior secured, unsecured and mezzanine loans, as well as corporate bonds, equity securities and structured products, primarily targeting U.S. middle-market companies with enterprise values of $50 M-$1 B and EBITDA of $10 M-$250 M.
Its investment universe spans business services, software & technology, healthcare, energy, consumer & retail, manufacturing, industrials, royalty-related businesses, education and specialty finance. Transaction sizes range from $15 M to $350 M, and the firm can arrange syndicated deals up to $500 M, allowing it to hold sizable positions across the capital structure.
As of the latest quarter (Q4 2023), TSLX reported a net asset value of $1.42 B, a weighted-average loan yield of 8.3% and a dividend yield of roughly 6.1%, reflecting the premium pricing of middle-market credit in a rising-rate environment. The fund’s performance has been bolstered by a 4.2% YoY increase in loan origination volume, driven by strong demand for flexible financing amid ongoing corporate refinancing activity and a resilient U.S. economic outlook.
For a deeper dive into TSLX’s valuation metrics and risk profile, consider exploring the analysis on ValueRay.
- Middle market loan demand impacts lending volume
- Interest rate changes affect net investment income
- Credit quality of portfolio companies drives losses
- Regulatory changes for BDCs influence operations
| Net Income: 170.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 0.04 > 1.0 |
| NWC/Revenue: -68.35% < 20% (prev -7.98%; Δ -60.37% < -1%) |
| CFO/TA 0.05 > 3% & CFO 180.3m > Net Income 170.5m |
| Net Debt (1.72b) to EBITDA (230.8m): 7.47 < 3 |
| Current Ratio: 0.18 > 1.5 & < 3 |
| Outstanding Shares: last quarter (94.7m) vs 12m ago 2.35% < -2% |
| Gross Margin: 72.84% > 18% (prev 0.70%; Δ 7.21k% > 0.5%) |
| Asset Turnover: 10.29% > 50% (prev 10.04%; Δ 0.24% > 0%) |
| Interest Coverage Ratio: 1.83 > 6 (EBITDA TTM 230.8m / Interest Expense TTM 105.6m) |
| A: -0.07 (Total Current Assets 53.8m - Total Current Liabilities 300.0m) / Total Assets 3.42b |
| B: 0.02 (Retained Earnings 81.6m / Total Assets 3.42b) |
| C: 0.06 (EBIT TTM 192.9m / Avg Total Assets 3.50b) |
| D: 0.05 (Book Value of Equity 82.6m / Total Liabilities 1.81b) |
| Altman-Z'' Score: 0.02 = B |
| DSRI: 1.12 (Receivables 34.1m/30.5m, Revenue 360.2m/359.7m) |
| GMI: 0.97 (GM 72.84% / 70.32%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.00 (Revenue 360.2m / 359.7m) |
| TATA: -0.00 (NI 170.5m - CFO 180.3m) / TA 3.42b) |
| Beneish M-Score: cannot calculate (missing components) |
Over the past week, the price has changed by +2.03%, over one month by +5.39%, over three months by -14.13% and over the past year by -11.47%.
- StrongBuy: 5
- Buy: 5
- Hold: 1
- Sell: 0
- StrongSell: 0
| Wallstreet Target Price | 22.1 | 20.2% |
| Analysts Target Price | 22.1 | 20.2% |
P/E Forward = 9.1241
P/S = 3.6907
P/B = 1.0456
P/EG = 1.2745
Revenue TTM = 360.2m USD
EBIT TTM = 192.9m USD
EBITDA TTM = 230.8m USD
Long Term Debt = 1.44b USD (estimated: total debt 1.74b - short term 300.0m)
Short Term Debt = 300.0m USD (from shortTermDebt, last quarter)
Debt = 1.74b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.72b USD (from netDebt column, last quarter)
Enterprise Value = 3.38b USD (1.66b + Debt 1.74b - CCE 19.7m)
Interest Coverage Ratio = 1.83 (Ebit TTM 192.9m / Interest Expense TTM 105.6m)
EV/FCF = 18.75x (Enterprise Value 3.38b / FCF TTM 180.3m)
FCF Yield = 5.33% (FCF TTM 180.3m / Enterprise Value 3.38b)
FCF Margin = 50.05% (FCF TTM 180.3m / Revenue TTM 360.2m)
Net Margin = 47.34% (Net Income TTM 170.5m / Revenue TTM 360.2m)
Gross Margin = 72.84% ((Revenue TTM 360.2m - Cost of Revenue TTM 97.8m) / Revenue TTM)
Gross Margin QoQ = 76.83% (prev 70.57%)
Tobins Q-Ratio = 0.99 (Enterprise Value 3.38b / Total Assets 3.42b)
Interest Expense / Debt = 1.61% (Interest Expense 28.0m / Debt 1.74b)
Taxrate = 4.44% (1.39m / 31.4m)
NOPAT = 184.3m (EBIT 192.9m * (1 - 4.44%))
Current Ratio = 0.18 (Total Current Assets 53.8m / Total Current Liabilities 300.0m)
Debt / Equity = 1.08 (Debt 1.74b / totalStockholderEquity, last quarter 1.61b)
Debt / EBITDA = 7.47 (Net Debt 1.72b / EBITDA 230.8m)
Debt / FCF = 9.56 (Net Debt 1.72b / FCF TTM 180.3m)
Total Stockholder Equity = 1.61b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.87% (Net Income 170.5m / Total Assets 3.42b)
RoE = 10.58% (Net Income TTM 170.5m / Total Stockholder Equity 1.61b)
RoCE = 6.31% (EBIT 192.9m / Capital Employed (Equity 1.61b + L.T.Debt 1.44b))
RoIC = 5.42% (NOPAT 184.3m / Invested Capital 3.40b)
WACC = 4.59% (E(1.66b)/V(3.40b) * Re(7.80%) + D(1.74b)/V(3.40b) * Rd(1.61%) * (1-Tc(0.04)))
Discount Rate = 7.80% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 100.0 | Cagr: 3.84%
[DCF] Terminal Value 80.82% ; FCFF base≈183.1m ; Y1≈120.2m ; Y5≈55.0m
[DCF] Fair Price = 0.22 (EV 1.74b - Net Debt 1.72b = Equity 21.2m / Shares 94.7m; r=6.0% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -24.95 | EPS CAGR: -42.90% | SUE: -4.0 | # QB: 0
Revenue Correlation: 42.22 | Revenue CAGR: 15.35% | SUE: -2.31 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.49 | Chg7d=-0.001 | Chg30d=-0.004 | Revisions Net=-3 | Analysts=10
EPS current Year (2026-12-31): EPS=1.98 | Chg7d=-0.005 | Chg30d=-0.015 | Revisions Net=-3 | Growth EPS=-15.1% | Growth Revenue=-8.5%
EPS next Year (2027-12-31): EPS=1.95 | Chg7d=-0.009 | Chg30d=-0.004 | Revisions Net=+0 | Growth EPS=-1.5% | Growth Revenue=+0.6%
[Analyst] Revisions Ratio: -0.60 (1 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -2.4% (Discount Rate 7.9% - Earnings Yield 10.3%)
[Growth] Growth Spread = -7.5% (Analyst -9.9% - Implied -2.4%)